Cancer Vaccine Analytical Characterization Service

Our cancer vaccine development support team will apply a comprehensive methodology to evaluate the carbohydrate, lipopolysaccharide, lipid, protein, glycoprotein, and lipoprotein components of the vaccine. Our experts use advanced technology platforms such as high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) to carry out vaccine development and research, including vaccine stability research and vaccine release testing. To help clients obtain an accurate data report for the projects, we provide comprehensive quality assurance expertise in compliance with the regulatory standards of quality and safety.